Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars

Galderma R&D20 enrolled

Overview

The purpose of this study is to assess the efficacy and safety of Adapalene Gel 0.3% in the treatment of atrophic acne scars.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Acne Scars

Interventions

AdapaleneDRUG

Adapalene Gel 0.3%

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female subjects of any race, aged 18 to 50 years inclusive * Subjects with a past history of acne and with moderate to severe facial atrophic acne scars Exclusion Criteria: * Subjects with active inflammatory acne lesions * Subjects with hypertrophic acne scars

Locations (1)

Manisha PATEL

Baltimore, Maryland, United States

Outcomes

Primary Outcomes

Global Scarring Severity

Grade Level: 1. Macular disease 2. Mild disease 3. Moderate disease 4. Severe disease

Time frame: Week 24

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.